Design of Evidence-Based Decision-Making Pathway for the Selection of the National Essential Medicines List
- VernacularTitle:国家基本药物目录遴选循证决策路径设计
- Author:
Haili ZHANG
1
;
Wenjie CAO
1
;
Yijiu YANG
1
;
Weili WANG
1
;
Ning LIANG
1
;
Ziteng HU
1
;
Bin LIU
1
;
Lijiao YAN
1
;
Huizhen LI
1
;
Zhaoyuan GONG
1
;
Guozhen ZHAO
1
;
Yanping WANG
1
;
Nannan SHI
1
Author Information
- Publication Type:Journal Article
- Keywords: Essential Medicine List; evidence-based decision-making; selection process; health policy
- From: Chinese Health Economics 2025;44(1):15-19
- CountryChina
- Language:Chinese
- Abstract: The National Essential Medicines System could protect public health and ensure access to essential medications.Although the current selection methods for China's National Essential Medicines Lists(NEMLs)are becoming more scientific and standardized,there are still problems such as much emphasis on expert experience and the lack of transparency of decision-making basis.To address these issues,it proposes an evidence-based decision-making pathway for NEMLs selection guided by clinical value.This approach ensures a strong integration of evidence and decision-making,offering valuable insights for improving the adjustment procedures and selection criteria of the NEMLs in China.
